US2017369907A1PendingUtilityA1

Methods of producing 7-carbon chemicals via pyruvate and succinate semialdehyde aldol condensation

Assignee: INVISTA NORTH AMERICA S Á R LPriority: Dec 31, 2012Filed: Jun 29, 2017Published: Dec 28, 2017
Est. expiryDec 31, 2032(~6.4 yrs left)· nominal 20-yr term from priority
C12P 7/24C12P 7/18C12P 7/44C12N 9/0006C12P 7/42C12N 15/52C12P 13/001C12P 7/40C12P 13/002
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This document describes biochemical pathways for producing one or more of pimelic acid, 7-aminoheptanoic acid, 7-hydroxyheptanoic acid, heptamethylenediamine and 1,7-heptanediol by forming one or two terminal functional groups, comprised of carboxyl, amine or hydroxyl groups, in a C7 aliphatic backbone substrate produced from succinate semialdehyde or pyruvate. These pathways, metabolic engineering and cultivation strategies described herein rely on the aldol condensation of succinate semialdehyde and pyruvate.

Claims

exact text as granted — not AI-modified
1 - 40 . (canceled) 
     
     
         41 . A method for biosynthesizing at least one product chosen from pimelic acid, 7-hydroxyheptanoate, heptamethylenediamine, and 1,7-heptanediol, said method comprising:
 enzymatically synthesizing a seven carbon chain aliphatic backbone from succinate semialdehyde and pyruvate via aldol condensation, wherein the aldol condensation comprises an aldol reaction catalyzed by a 4-hydroxy-2-oxopimelate aldolase and a dehydration catalyzed by a 2-hydroxyhepta-2,4-dienedioate hydratase; and   enzymatically forming two terminal functional groups chosen from carboxyl, amine, and hydroxyl groups in said seven carbon chain aliphatic backbone, thereby forming said at least one product.   
     
     
         42 . The method of  claim 41 , wherein said seven carbon chain aliphatic backbone is pimeloyl-CoA or pimelate semialdehyde. 
     
     
         43 . The method of  claim 41 , wherein the product of the aldol condensation, 2,4-dihydroxyhept-2-enedioate or its tautomer 4-hydroxy-2-oxo-pimelate, is converted to:
 pimeloyl-CoA using said 2-hydroxyhepta-2,4-dienedioate hydratase and at least one enzyme chosen from: an enoate reductase; a 2-hydroxyglutarate dehydrogenase; a glutaconate CoA-transferase; a 2-hydroxyglutaryl-CoA dehydratase; and an enoyl-CoA reductase or an enoyl-[acp] reductase; or   pimelate semialdehyde using said 2-hydroxyhepta-2,4-dienedioate hydratase and at least one enzyme chosen from: an enoate reductase; a 2-hydroxyglutarate dehydrogenase; a glutaconate CoA-transferase; a 2-hydroxyglutaryl-CoA dehydratase; and a carboxylate reductase.   
     
     
         44 . The method of  claim 43 , wherein said enoate reductase has at least 70% sequence identity to the amino acid sequence set forth in SEQ ID NO: 16 or SEQ ID NO: 17. 
     
     
         45 . The method of  claim 41 , wherein said at least one product comprises two terminal amine groups, two terminal carboxyl groups, two terminal hydroxyl groups, or a terminal hydroxyl group and a terminal carboxyl group. 
     
     
         46 . The method of  claim 45 , wherein a 6-hydroxyhexanoate dehydrogenase, a 5-hydroxypentanoate dehydrogenase, a 4-hydroxybutyrate dehydratase, or an alcohol dehydrogenase enzymatically forms said two terminal hydroxyl groups. 
     
     
         47 . The method of  claim 41 , wherein a thioesterase, an aldehyde dehydrogenase, a 7-oxoheptanoate dehydrogenase, a 6-oxohexanoate dehydrogenase, a CoA-transferase, or a reversible CoA-ligase enzymatically forms a terminal carboxyl group. 
     
     
         48 . The method of  claim 47 , wherein said thioesterase has at least 70% sequence identity to the amino acid sequence set forth in SEQ ID NO: 1. 
     
     
         49 . The method of  claim 41 , wherein a ω-transaminase or a deacetylase enzymatically forms a terminal amine group. 
     
     
         50 . The method of  claim 49 , wherein said ω-transaminase has at least 70% sequence identity to any one of the amino acid sequences set forth in SEQ ID NOs: 8-13. 
     
     
         51 . The method of  claim 41 , wherein a carboxylate reductase, enhanced by a phosphopantetheinyl transferase, forms a terminal aldehyde group as an intermediate in forming the product. 
     
     
         52 . The method of  claim 51 , wherein said carboxylate reductase has at least 70% sequence identity to any one of the amino acid sequences set forth in SEQ ID NOs: 2-7. 
     
     
         53 . The method of  claim 41 , wherein said method is performed in a recombinant host by fermentation. 
     
     
         54 . The method of  claim 53 , wherein the principal carbon source fed to said fermentation derives from a biological or non-biological feedstock. 
     
     
         55 . The method of  claim 54 , wherein:
 said biological feedstock is, or derives from, monosaccharides, disaccharides, lignocellulose, hemicellulose, cellulose, lignin, levulinic acid, formic acid, triglycerides, glycerol, fatty acids, agricultural waste, condensed distillers' solubles, or municipal waste; or   said non-biological feedstock is, or derives from, natural gas, syngas, CO 2 /H 2 , methanol, ethanol, benzoate, non-volatile residue (NVR) caustic wash waste stream from cyclohexane oxidation processes, or terephthalic acid/isophthalic acid mixture waste streams.   
     
     
         56 . The method of  claim 53 , wherein said recombinant host is a prokaryote or a eukaryote. 
     
     
         57 . The method of  claim 53 , wherein said recombinant host's tolerance to high concentrations of a C7 building block is improved through continuous cultivation in a selective environment. 
     
     
         58 . The method of  claim 53 , wherein said recombinant host comprises at least one attenuated enzyme chosen from: a lactate dehydrogenase; a menaquinol-fumarate oxidoreductase; an alcohol dehydrogenase producing ethanol; a pyruvate decarboxylase; a 2-oxoacid decarboxylase generating isobutanol; a polymer synthase; a NADH-specific L-glutamate dehydrogenase; a NADH-consuming transhydrogenase; a pimeloyl-CoA dehydrogenase; an acyl-CoA dehydrogenase that degrades C7 building blocks and their precursors; a glutaryl-CoA dehydrogenase; and a pimeloyl-CoA synthetase. 
     
     
         59 . The method of  claim 53 , wherein said recombinant host overexpresses at least one gene encoding a gene product chosen from: a PEP carboxykinase; a PEP carboxylase; a pyruvate carboxylase; a PEP synthase; a formate dehydrogenase; a L-alanine dehydrogenase; a NADPH-specific L-glutamate dehydrogenase; a diamine transporter, a dicarboxylate transporter; and a multidrug transporter. 
     
     
         60 . A recombinant host comprising at least one exogenous nucleic acid encoding a 4-hydroxy-2-oxopimelate aldolase, a 2-hydroxyhepta-2,4-dienedioate hydratase, an enoate reductase, a 2-hydroxyglutarate dehydrogenase, a glutaconate CoA-transferase, a 2-hydroxyglutaryl-CoA dehydratase, and an enoyl-CoA reductase or an enoyl-[acp] reductase, said host producing pimeloyl-CoA. 
     
     
         61 . A recombinant host comprising at least one exogenous nucleic acid encoding a 4-hydroxy-2-oxopimelate aldolase, a 2-hydroxyhepta-2,4-dienedioate hydratase, an enoate reductase, a 2-hydroxyglutarate dehydrogenase, a glutaconate CoA-transferase, a 2-hydroxyglutaryl-CoA dehydratase, and a carboxylate reductase, said host producing pimelate semialdehyde.

Join the waitlist — get patent alerts

Track US2017369907A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.